A nonparametric methodological analysis of rest-activity rhythm in type 2 diabetes

 

 Permissions and Reprints

The purpose of this study was to analyze the rest-activity rhythm of type 2 diabetics mellitus (T2DM) and compare it to healthy controls using the nonparametric analytic approach. Twenty-one diabetics and 21 healthy subjects matched for gender and age were recruited to participate in the study. Data were analyzed using the Independent t-test, Mann-Whitney U test, and Spearmans correlation. T2DM subjects demonstrate lower interdaily stability (IS) (p=.03), higher intradaily variability (p=.046) and lower rhythm amplitude (p=.02) when compared to healthy controls. Also, there was a positive correlation between IS and most active 10 hr (M10) in the average of 24 hours pattern (r =.44; p=.046) in the diabetes group and a negative correlation between IV and M10 in the healthy group (r =-.57; p=.007). These data together suggest that T2DM exhibits a dysfunction in the rest-activity rhythm due to alterations in the circadian function as well as in the homeostatic capacity to maintain sleep; mainly characterized by less consistency across days of the daily circadian signal, higher rhythm fragmentation and lower rhythm amplitude. Future approaches may be developed considering the influence of circadian glucose variations throughout the day on the coupling of the rest-activity rhythm to zeitgeber and rhythm fragmentation.

Publication History

Received: 29 July 2017

Accepted: 27 August 2018

Article published online:
16 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• REFERENCES

• 1 Department of Health and Human Services (CDCP). Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: Department of Health and Human; 2011.
• 2 Centers for Disease Control and Prevention (CDCP). National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. Atlanta: Centers for Disease Control and Prevention; 2017.
• 3 Plantinga L, Rao MN, Schillinger D. Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005-2008. Prev Chronic Dis. 2012;9:E76.
• 4 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
• 5 World Health Organization (WHO). Methods and data sources for country- level causes of death 2000-2015. Geneva: World Health Organization;2017.
• 6 Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol. 2009;5(5):253-61.
• 7 Van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, et al. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res. 2007;67(Suppl 1):2-9.
• 8 Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165(8):863-7.
• 9 Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991;88(3):934-42.
• 10 Laposky AD, Bass J, Kohsaka A, Turek FW. Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett. 2008;582(1):142-51.
• 11 Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev. 2009;10(Suppl 2):37-45.
• 12 Dijk DJ, von Schantz M. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J Biol Rhythms. 2005;20(4):279-90.
• 13 Buijs RM, Scheer FA, Kreier F, Yi C, Bos N, Goncharuk VD, et al. Organization of circadian functions: interaction with the body. Prog Brain Res. 2006;153:341-60.
• 14 Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010;330(6009):1349-54.
• 15 Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the circadian clock in the liver by feeding. Science. 2001;291(5503):490-3.
• 16 Young ME, Bray MS. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med. 2007;8(6):656-67.
• 17 Carneiro BT, Araujo JF. The food-entrainable oscillator: a network of interconnected brain structures entrained by humoral signals? Chronobiol Int. 2009;26(7):1273-89.
• 18 Carneiro BTS, Fernandes DAC, Medeiros CFP, Diniz NL, Araujo JF. Daily anticipatory rhythms of behavior and body temperature in response to glucose availability in rats. Psychol Neurosci. 2012;5(2):191-7.
• 19 Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-93.
• 20 Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290(4):486-94.
• 21 American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes Care. 2012;35(Suppl 1):S11-63.
• 22 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854-65.
• 23 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
• 24 Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342-92.
• 25 Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol Psychiatry. 1990;27(6):563-72.
• 26 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.
• 27 International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34.
• 28 Hartemann-Heurtier A, Sultan S, Sachon C, Bosquet F, Grimaldi A. How type 1 diabetic patients with good or poor glycemic control cope with diabetes-related stress. Diabetes Metab. 2001;27(5 Pt 1):553-9.
• 29 Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006-2009. Prev Chronic Dis. 2012;9:120065.
• 30 Contreras S, Fernandez S, Malcarne VL, Ingram RE, Vaccarino VR. Reliability and Validity of the Beck Depression and Anxiety Inventories in Caucasian Americans and Latinos. Hisp J Behav Sci. 2004;26(4):446-62.
• 31 Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology. 1998;31(3):160-8.
• 32 Levendowski DJ, Olmstead R, Popovic D, Carper DL, Berka C, Westbrook PR. Assessment of Obstructive Sleep Apnea Risk and Severity in Truck Drivers: Validation of a Screening Questionnaire. Sleep Diagn Therapy. 2007;2(2):20-6.
• 33 Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. American Sleep Disorders Association. Sleep. 1995;18(4):285-7.
• 34 Van Someren EJ, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry. 1997;41(9):955-63.
• 35 Huang YL, Liu RY, Wang QS, Van Someren EJ, Xu H, Zhou JN. Ageassociated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav. 2002;76(4-5):597-603.
• 36 Calogiuri G, Weydahl A, Carandente F. Methodological issues for studying the rest-activity cycle and sleep disturbances: a chronobiological approach using actigraphy data. Biol Res Nurs. 2013;15(1):5-12.
• 37 Kadono M, Nakanishi N, Yamazaki M, Hasegawa G, Nakamura N, Fukui M. Various patterns of disrupted daily rest-activity rhythmicity associated with diabetes. J Sleep Res. 2016;25(4):426-37.
• 38 Van Someren EJ, Lijzenga C, Mirmiran M, Swaab DF. Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms. 1997;12(2):146-56.
• 39 Lamond N, Tiggemann M, Dawson D. Factors predicting sleep disruption in Type II diabetes. Sleep. 2000;23(3):415-6.
• 40 Knutson KL, Van Cauter E, Zee P, Liu K, Lauderdale DS. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care. 2011;34(5):1171-6.
• 41 Trento M, Broglio F, Riganti F, Basile M, Borgo E, Kucich C, et al. Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol. 2008;45(4):225-9.
• 42 Whitehead DL, Davies AD, Playfer JR, Turnbull CJ. Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov Disord. 2008;23(8):1137-45.
• 43 Cavalcanti PR, Campos TF, Araujo JF. Circadian and homeostatic changes of sleep-wake and quality of life in stroke: implications for neurorehabilitation. NeuroRehabilitation. 2013;32(2):337-43.
• 44 Cavalcanti P, Campos T, Araujo J. Actigraphic analysis of the sleep-wake cycle and physical activity level in patients with stroke: implications for clinical practice. Chronobiol Int. 2012;29(9):1267-72.
• 45 van Someren EJ, Hagebeuk EE, Lijzenga C, Scheltens P, de Rooij SE, Jonker C, et al. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry. 1996;40(4):259-70.
• 46 Jean-Louis G, Zizi F, Lazzaro DR, Wolintz AH. Circadian rhythm dysfunction in glaucoma: A hypothesis. J Circadian Rhythms. 2008;6:1.
• 47 Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich). 2011;13(4):244-51.
• 48 Pouvreau C, Dayre A, Butkowski EG, de Jong B, Jelinek HF. Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res. 2018;11:61-8.
• 49 Ndisang JF, Vannacci A, Rastogi S. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxid Med Cell Longev. 2014;2014:506948.
• 50 Dhillon S, Chung SA, Fargher T, Huterer N, Shapiro CM. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens. 2005;18(5 Pt 1):594-600.
• 51 Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491-7.
• 52 Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35-42.
• 53 Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380-4.
• 54 Choi KM, Lee JS, Park HS, Baik SH, Choi DS, Kim SM. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes (Lond). 2008;32(7):1091-7.